1. Home
  2. WEN vs OCS Comparison

WEN vs OCS Comparison

Compare WEN & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$6.80

Market Cap

1.4B

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$27.53

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEN
OCS
Founded
1969
2003
Country
United States
Switzerland
Employees
N/A
3
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
WEN
OCS
Price
$6.80
$27.53
Analyst Decision
Hold
Strong Buy
Analyst Count
22
6
Target Price
$8.88
$42.00
AVG Volume (30 Days)
7.2M
190.5K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
8.26%
N/A
EPS Growth
N/A
N/A
EPS
0.85
N/A
Revenue
$2,176,891,000.00
N/A
Revenue This Year
$2.35
$466.06
Revenue Next Year
$0.94
$479.73
P/E Ratio
$7.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.63
$16.00
52 Week High
$13.06
$30.68

Technical Indicators

Market Signals
Indicator
WEN
OCS
Relative Strength Index (RSI) 40.44 56.96
Support Level $6.73 $19.00
Resistance Level $7.34 $27.93
Average True Range (ATR) 0.25 1.05
MACD 0.01 0.25
Stochastic Oscillator 22.95 78.64

Price Performance

Historical Comparison
WEN
OCS

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: